The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
Although much progress has been made for the treatment of prostate cancer, patients with advanced prostate cancer still have a poor 5 year survival rate. Current practices for hormone-refractory/castrate resistant, metastatic prostate cancer involve the use of taxanes. Docetaxel, in particular, is b...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
OMICS Publishing Group
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/37841 |